Swiss Medical Weekly (Feb 2013)

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries

  • Jakob Passweg,
  • Helen Baldomero,
  • Mario Bargetzi,
  • Christoph Bucher,
  • Yves Chalandon,
  • Michel A. Duchosal,
  • Alois Gratwohl,
  • Tayfun Güngör,
  • Urs Hess,
  • Kurt Leibundgut,
  • Grazia Nicoloso de Faveri,
  • Hulya Ozsahin,
  • Thomas Pabst,
  • Christoph Renner,
  • Martin Stern,
  • Georg Stussi,
  • Urs Schanz,
  • for the SBST (Swiss Blood Stem Cell Transplantation Group)

DOI
https://doi.org/10.4414/smw.2013.13757
Journal volume & issue
Vol. 143, no. 0708

Abstract

Read online

Haematopoietic stem cell transplantation (HSCT) is a highly specialised procedure used to treat malignancies of the lymphohaematopoietic system as well as some acquired and inherited disorders of the blood. This analysis by the Swiss Blood Stem Cell Transplantation Group, based on data from 2008–2011, describes, treatment rates in Switzerland for specific indications and compares this with data from Germany, France, Italy and the Netherlands, corrected for the size of the population. Differences in transplant rates, in rates for particular indications, and in the use of specific transplant technologies such as use of unrelated donors, use of cord blood or mismatched family donors are described. These data are put in correlation with donor availability from international registries and with number of transplant teams and number of procedures per team all corrected for population size.

Keywords